QCM
NUVB icon

Quantinno Capital Management’s Nuvation Bio NUVB Stock Holding History

Quantinno Capital Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.36M Buy
239,521
+100,264
+72% +$490K ﹤0.01% 2313
2026
Q1 		$597K Buy
139,257
+98,158
+239% +$547K ﹤0.01% 2581
2025
Q4 		$368K Buy
+41,099
New +$255K ﹤0.01% 2695

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Quantinno Capital Management's NUVB Position: Q2 2026 in Review

Quantinno Capital Management increased its Nuvation Bio (NUVB) stake by 72% in Q2 2026, buying an estimated $490K and bringing the position to 239,521 shares worth $1.36M. The position accounts for ﹤0.01% of the portfolio, ranked #2313.

Quantinno Capital Management first reported a position in NUVB in Q4 2025 and has held it in 3 quarters since. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Quantinno Capital Management held 239,521 shares of Nuvation Bio worth $1.36M as of Q2 2026.
  • Quantinno Capital Management bought 100,264 Nuvation Bio shares in Q2 2026, an estimated $490K.
  • Nuvation Bio made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #2313 holding.
  • Quantinno Capital Management first reported a position in Nuvation Bio in Q4 2025 and has held it in 3 quarters since.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.